Cork Startup ArrayPatch Raises €1.6 Million More to Take a Dissolving GLP-1 Microneedle Patch Toward Human Studies
ArrayPatch, a University College Cork spin-out, closed a second seed round of €1.6 million, bringing its total to €3.2 million, with WakeUp Capital co-leading, the Irish Examiner reported on November 10. The company says the microneedles in its DerMap patch are made entirely of the drug being delivered, with no polymer, and it will use the money to move its lead GLP-DerMap program for obesity and diabetes toward first-in-human studies.